Veritas Pharma Inc.

Recent News

  • Veritas Pharma Advances Fifth of Six Equal Payments to Cannevert Therapeutics Ltd.

    Vancouver, British Columbia--(Newsfile Corp. - January 23, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, is pleased to announce that it has completed its second to last payment of $250,000 to Cannevert Therapeutics Ltd. (CTL). This latest installment brings...

    2017-01-23 7:04 PM ET
  • Veritas Receives Listing on the Xetra(R) (Frankfurt, Germany) Trading Venue

    Vancouver, British Columbia--(Newsfile Corp. - December 7, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, is pleased to announce that as of December 7th, 2016, its common shares are accepted for continuous trading on the electronic trading platform XETRA®...

    2016-12-07 7:02 PM ET
  • Report on Canada's Marijuana Legalization is Anticipated to be Released This Week

    Vancouver, British Columbia--(Newsfile Corp. - November 29, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("VRT" or the "Company") is eagerly awaiting the report of the Task Force on Marijuana Legalization to be delivered by its Chair, Anne McLellan to the Canadian Federal Cabinet by this...

    2016-11-29 9:36 AM ET
  • Veritas Pharma Inc. Management Discussion and Analysis Amendment and Restatement

    Vancouver, British Columbia--(Newsfile Corp. - November 25, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), ("Veritas" or the "Company"), as a result of a review by the British Columbia Securities Commission, is issuing the following press release to clarify our disclosure. We have amended and restated...

    2016-11-25 5:05 PM ET
  • Veritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing Facility

    Vancouver, British Columbia--(Newsfile Corp. - November 21, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), ("Veritas" or the "Company"), an emerging-stage pharmaceutical and IP development company, is pleased to announce that it has signed a Letter of Intent ("LOI") with Sechelt Organic Marijuana Inc. ("Privco"), whereby...

    2016-11-21 9:00 AM ET
  • Veritas Announces an Expansion to the Private Placement and Engages European Healthcare Capital

    Vancouver, British Columbia--(Newsfile Corp. - November 16, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, has expanded the private placement offering announced on September 16th and has engaged the European Healthcare Capital ("EHC") to grow investor awareness of medical...

    2016-11-16 8:41 AM ET
  • Veritas Pharma Inc. Management Discussion and Analysis Amendment and Restatement

    Vancouver, British Columbia--(Newsfile Corp. - November 9, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), ("Veritas" or the "Company"), as a result of a review by the British Columbia Securities Commission, is issuing the following press release to clarify our disclosure. We have amended and restated...

    2016-11-09 11:51 PM ET
  • Veritas Approves Issue of Stock Options

    Vancouver, British Columbia--(Newsfile Corp. - September 6, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("VRT" or the "Company"), an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis (nausea/vomiting), and epilepsy, today announced that 1,000,000 stock...

    2016-09-06 9:00 AM ET